These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25672715)
1. [Motor nerve hyperexcitability in ALS: its pathophysiology and treatment]. Shibuya K; Misawa S; Kuwabara S Rinsho Shinkeigaku; 2014; 54(12):1086-8. PubMed ID: 25672715 [TBL] [Abstract][Full Text] [Related]
2. A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial. Shibuya K; Misawa S; Kimura H; Noto Y; Sato Y; Sekiguchi Y; Iwai Y; Mitsuma S; Beppu M; Watanabe K; Fujimaki Y; Tsuji Y; Shimizu T; Mizuno T; Nakagawa M; Sawaguchi K; Hanaoka H; Kuwabara S Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):353-8. PubMed ID: 25960085 [TBL] [Abstract][Full Text] [Related]
3. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial. Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N; Muscle Nerve; 2021 Mar; 63(3):371-383. PubMed ID: 33340120 [TBL] [Abstract][Full Text] [Related]
4. [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options]. Kuwabara S Brain Nerve; 2010 Aug; 62(8):885-91. PubMed ID: 20714037 [TBL] [Abstract][Full Text] [Related]
5. [Altered axonal ion channel function in amyotrophic lateral sclerosis]. Kuwabara S; Kanai K Brain Nerve; 2007 Oct; 59(10):1109-15. PubMed ID: 17969351 [TBL] [Abstract][Full Text] [Related]
6. Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. Iwai Y; Shibuya K; Misawa S; Sekiguchi Y; Watanabe K; Amino H; Kuwabara S PLoS One; 2016; 11(7):e0158596. PubMed ID: 27383069 [TBL] [Abstract][Full Text] [Related]
7. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388 [TBL] [Abstract][Full Text] [Related]
8. Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis. Noto YI; Simon NG; Selby A; Garg N; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Park SB; Vucic S; Kiernan MC Clin Neurophysiol; 2018 May; 129(5):974-980. PubMed ID: 29554580 [TBL] [Abstract][Full Text] [Related]
9. [Abnormal hyperexcitability in ALS]. Kohara N Rinsho Shinkeigaku; 1999 Jan; 39(1):61-4. PubMed ID: 10377805 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of mexiletine in amyotrophic lateral sclerosis: a systematic review of randomized controlled trials. Adiao KJB; Espiritu AI; Bagnas MAC Neurodegener Dis Manag; 2020 Dec; 10(6):397-407. PubMed ID: 32867586 [No Abstract] [Full Text] [Related]
11. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis. Noto Y; Shibuya K; Vucic S; Kiernan MC Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534 [TBL] [Abstract][Full Text] [Related]
12. Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study. Shibuya K; Misawa S; Arai K; Nakata M; Kanai K; Yoshiyama Y; Ito K; Isose S; Noto Y; Nasu S; Sekiguchi Y; Fujimaki Y; Ohmori S; Kitamura H; Sato Y; Kuwabara S Exp Neurol; 2011 Dec; 232(2):149-53. PubMed ID: 21906595 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression. Weiss MD; Macklin EA; Simmons Z; Knox AS; Greenblatt DJ; Atassi N; Graves M; Parziale N; Salameh JS; Quinn C; Brown RH; Distad JB; Trivedi J; Shefner JM; Barohn RJ; Pestronk A; Swenson A; Cudkowicz ME; Neurology; 2016 Apr; 86(16):1474-81. PubMed ID: 26911633 [TBL] [Abstract][Full Text] [Related]
14. Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons. Shibuya K; Misawa S; Nasu S; Sekiguchi Y; Mitsuma S; Beppu M; Ohmori S; Iwai Y; Ito S; Kanai K; Sato Y; Kuwabara S J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):969-72. PubMed ID: 23467416 [TBL] [Abstract][Full Text] [Related]
15. Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance. de Carvalho M; Kiernan MC; Swash M J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):773-779. PubMed ID: 28490504 [TBL] [Abstract][Full Text] [Related]
19. Distal motor axonal dysfunction in amyotrophic lateral sclerosis. Noto Y; Kanai K; Misawa S; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Nakagawa M; Kuwabara S J Neurol Sci; 2011 Mar; 302(1-2):58-62. PubMed ID: 21195434 [TBL] [Abstract][Full Text] [Related]
20. Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy. Do-Ha D; Buskila Y; Ooi L Mol Neurobiol; 2018 Feb; 55(2):1410-1418. PubMed ID: 28160214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]